Optimal timing and drug combination of selinexor in multiple myeloma: a systematic review and meta-analysis
ABSTRACTObjectives Multiple myeloma (MM) remains an incurable disease despite advances in treatment options. Recently, selinexor has shown promising efficacy for relapsed/refractory multiple myeloma (RRMM), whereas its optimal timing and drug combination remain unclear. In order to assess the variou...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
Taylor & Francis Group
2023-12-01
|
| Sraith: | Hematology |
| Ábhair: | |
| Rochtain ar líne: | https://www.tandfonline.com/doi/10.1080/16078454.2023.2187972 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|